Sapanisertib Plus Exemestane or Fulvestrant in Women with Hormone Receptor–Positive/HER2-Negative Advanced or Metastatic Breast Cancer
暂无分享，去创建一个
R. Neuwirth | J. Canon | K. Galinsky | J. Diamond | M. Danso | D. Potter | T. Haddad | A. Awada | B. Lim | E. Tan-chiu | A. Lortholary | B. Bahamon | P. Silverman | C. Patel | H. Bourgeois | E. Leonard | F. Forget | M. Salkeni | S. Vincent